Checking treatment response
PET-CT to Check Response — in Breast Cancer
If you are having chemotherapy before breast cancer surgery, a PET-CT scan can show whether the treatment is working — before the surgeon operates. This page explains when the scan is done, what it measures, and what the result means for your next step.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Not for early-stage disease — PET-CT response assessment is used for locally advanced breast cancer, not early-stage.
- Two scans are compared — A baseline scan before chemotherapy is set against a scan taken partway through or after treatment.
- It measures metabolic activity — The scan tracks how much glucose tumour cells are absorbing — a direct measure of their activity.
- Surgery gives the final answer — PET-CT informs the plan; the pathology report from the tissue removed at surgery is the definitive measure.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
PET-CT compares metabolic activity in your breast tumour before and during neoadjuvant chemotherapy. A significant drop in glucose uptake between the two scans suggests the cancer is responding. It is used for locally advanced disease and is not part of the standard pathway for early-stage breast cancer.
A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.
When is PET-CT used to check breast cancer response?
PET-CT for response assessment is used during neoadjuvant chemotherapy — treatment given before surgery to reduce the size of the tumour. It is appropriate for locally advanced breast cancer, which typically means stage III disease or bulky stage II.
For early-stage breast cancer — stage I and most stage II — NCCN and ESMO guidance does not recommend PET-CT as part of response monitoring. The result would not change how treatment is managed in those situations.
Your oncologist decides whether a response scan belongs in your plan, based on your stage and what the result would actually change.
What does PET-CT compare, and what does it actually measure?
PET-CT measures glucose uptake. Cancer cells are more metabolically active than normal tissue and absorb more of the tracer — a radioactive sugar called FDG — which shows up as bright areas on the scan.
A baseline scan is taken before chemotherapy begins. A second scan is taken at an agreed point: often after several cycles, or at the end of the full course.
The two scans are compared side by side. The question is whether the bright areas have become less active — a sign that the chemotherapy is killing cancer cells.
How does response assessment with PET-CT work?
Baseline scan
Done before chemotherapy starts. FDG records the metabolic activity of the tumour and any involved lymph nodes. This is the reference image everything else is compared against.
Chemotherapy cycles
Treatment runs according to your oncologist's plan. A single well-timed comparison gives more information than scanning after every cycle.
Response scan
A second PET-CT is done at a point your oncologist specifies. The timing depends on your treatment regimen and tumour biology.
Reporting
A radiologist trained in oncology imaging measures the change in FDG uptake and reports the degree of metabolic response.
Treatment review
Your oncologist uses the result alongside examination findings to decide whether to proceed to surgery as planned or to adjust the treatment approach.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What does a good response on PET-CT look like?
A good response means significantly reduced glucose uptake in the tumour between the two scans. This is called a metabolic response, and it indicates that cancer cells are dying.
The result your oncologist looks for most is near-complete loss of FDG activity — a metabolic complete response. This is associated with a better chance of finding little or no residual cancer at surgery, though the scan cannot confirm that in advance.
The definitive measure is the pathology report from the tissue removed at surgery. PET-CT informs the plan before surgery; it does not replace the surgeon's findings.
What to prepare before your response scan
- Tell your team if you have diabetes — blood glucose levels affect how the FDG tracer is absorbed and may require scheduling adjustments.
- Follow the fasting instructions your centre gives you; food in the hours before the scan affects the result.
- Tell the radiographer which chemotherapy drugs you are on and when your last cycle was.
- Bring the report and images from your baseline scan if it was done at a different centre.
- Ask your oncologist in advance what result they are looking for and what it would mean for the next step.
Questions about PET-CT response assessment
What happens if PET-CT shows the tumour is not responding?
A poor metabolic response is important information, not a closed door. Your oncologist may consider switching to a different chemotherapy regimen, adjusting the treatment plan before surgery, or proceeding to surgery earlier and treating residual disease afterwards. The scan gives your team a chance to act on this while there is still time to change course — which is one of the main reasons response assessment is done at all.
Does a good PET-CT result mean there is no cancer left?
No, and this distinction matters. A metabolic complete response on PET-CT means glucose uptake has dropped to near-background levels, which is an encouraging sign. But microscopic cancer cells can remain without enough metabolic activity to appear on the scan. The pathology report from the tissue removed at surgery is the only way to confirm whether a pathological complete response has occurred. PET-CT predicts; it does not confirm.
Why was PET-CT not ordered for my relative with early breast cancer?
Because NCCN and ESMO guidance does not support it in early-stage disease. For stage I and most stage II breast cancers, the treatment pathway does not change based on a PET response scan, so the radiation exposure and cost are not justified. The absence of a response scan is not an oversight or a shortcut — it reflects the evidence for when PET adds meaningful information and when it does not.
How is PET-CT different from MRI for checking response?
MRI measures size and structural changes in the tumour. PET-CT measures metabolic activity. Both are used in neoadjuvant response assessment, and some centres use both for complementary information. MRI is generally preferred for measuring residual tumour size; PET-CT is more sensitive to early metabolic changes, which can appear before the tumour has visibly shrunk on imaging. Your oncologist chooses based on your situation and what the partner imaging centres can provide.
Can the treatment plan change based on a mid-treatment scan?
Yes, and this is one of the reasons response assessment exists. If a scan at an interim point shows poor metabolic response, your oncologist has the option to change course before you complete all cycles of a regimen that is not working. Whether that is the right call depends on your cancer subtype, the regimen, and the specific findings — it is a clinical conversation with your treating team, not an automatic consequence of a poor scan result.
Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.
Explore 100 more PET-CT for Your Cancer Type topics
Breast Cancer PET-CT
- Axillary Node Uptake on PET for Breast Cancer
- Bone Metastases in Breast Cancer: PET or Bone Scan?
- Breastfeeding and PET-CT Scans
- Incidental Breast Uptake Found on a Scan for Something Else
- Is a PET-CT Needed for Early Breast Cancer?
- PET-CT Cost for Breast Cancer Staging in Hyderabad
- PET-CT and Breast Implants
- PET-CT for Breast Cancer Recurrence
- PET-CT for Breast Cancer: When Is It Needed?
- PET-CT for Locally Advanced Breast Cancer
- PET-CT for Triple-Negative and HER2-Positive Breast Cancer
- PET-CT to Check Response in Breast Cancer
GI, Liver & Colorectal PET-CT
- Focal Bowel Uptake: When to Do a Colonoscopy
- Mucinous Tumours: Why PET Often Misses Them
- PET-CT Before Liver Resection or HIPEC
- PET-CT Cost for GI Cancer Staging in Hyderabad
- PET-CT for Colorectal Cancer
- PET-CT for Gallbladder and Bile Duct Cancer
- PET-CT for Liver Cancer (Hepatocellular Carcinoma)
- PET-CT for Liver Metastases: How Reliable?
- PET-CT for Oesophageal and Stomach Cancer
- PET-CT for Pancreatic Cancer
- Peritoneal Spread on PET-CT: What It Can and Cannot See
- Rising CEA With Normal Scans: Where Does PET Fit?
Gynaecological Cancer PET-CT
- PET-CT After Chemoradiation for Cervical Cancer
- PET-CT Cost for Gynaecological Cancer in Hyderabad
- PET-CT and Pregnancy: Why It Is Avoided
- PET-CT for Cervical Cancer
- PET-CT for Endometrial and Uterine Cancer
- PET-CT for Gestational Trophoblastic Disease
- PET-CT for Ovarian Cancer
- PET-CT for Vulvar and Vaginal Cancer
- Para-Aortic Node Uptake in Cervical Cancer
- Physiological Uterine and Ovarian Uptake
- Rising CA-125 With Normal Scans
- Why the Bladder Makes Pelvic PET Harder to Read
Head, Neck & Thyroid PET-CT
- Dental Work, Fillings and Artefacts on Head-Neck PET
- Neck Node Uptake on PET: What It Means
- PET-CT After Radiotherapy for Head and Neck Cancer
- PET-CT Cost for Head and Neck Cancer in Hyderabad
- PET-CT for Cancer of Unknown Primary in the Neck
- PET-CT for Head and Neck Cancer
- PET-CT for Nasopharyngeal Cancer
- PET-CT for Oral Cancer Staging
- PET-CT for Salivary Gland and Sinus Tumours
- PET-CT for Thyroid Cancer: When Is It Used?
- Rising Thyroglobulin With a Negative Iodine Scan
- Vocal Cord and Muscle Uptake in the Neck
Lung Cancer PET-CT
- Adrenal Findings During Lung Cancer Staging
- Brain Metastases: Why PET Is Not Enough for Lung Cancer
- Lung Nodule With High Uptake: Cancer or TB?
- Mediastinal Nodes on PET-CT: Staging the Chest
- PET-CT After Lung Cancer Treatment
- PET-CT Before Lung Cancer Surgery
- PET-CT Cost for Lung Cancer Staging in Hyderabad
- PET-CT for Lung Cancer: What It Shows
- PET-CT for Mesothelioma
- PET-CT for Small Cell Lung Cancer
- PET-CT for a Lung Nodule: Is It Cancer?
- Pleural Effusion and Pleural Uptake on PET
Lymphoma & Blood Cancer PET-CT
- Bone Marrow Involvement on PET in Lymphoma
- Deauville Score in Lymphoma: The Complete Guide
- End-of-Treatment PET in Lymphoma
- How Many PET Scans Will a Lymphoma Patient Need?
- Interim PET in Lymphoma: The Scan That Changes Treatment
- Lymphoma Staging on PET-CT: Ann Arbor and Lugano
- PET-CT Cost Across a Lymphoma Treatment Course
- PET-CT for Hodgkin vs Non-Hodgkin Lymphoma
- PET-CT for Lymphoma: Why It Matters More Here
- PET-CT for Multiple Myeloma
- PET-CT in Leukaemia: When Is It Used?
- Residual Mass After Lymphoma Treatment: Scar or Disease?
- Surveillance PET Scans After Lymphoma Remission
- Thymic Rebound and Marrow Uptake in Young Lymphoma Patients
Non-Oncology PET-CT
- Brain PET for Dementia and Memory Loss
- Brain PET for Epilepsy and Seizure Focus
- Cardiac PET for Heart Muscle Viability
- Cardiac PET for Sarcoidosis and Inflammation
- Does a Non-Cancer PET-CT Cost the Same?
- PET-CT for Fever of Unknown Origin
- PET-CT for Non-Cancer Conditions: Why You Have Been Referred
- PET-CT for Suspected Bone or Spine Infection
- PET-CT for Suspected Infection in Implants and Grafts
- PET-CT for Unexplained Weight Loss
- PET-CT for Vasculitis and Large Vessel Inflammation
- Preparation for a Cardiac or Brain PET Scan
- What If a Non-Cancer PET Scan Finds Something Suspicious?
- Who Reports a Non-Oncology PET Scan?
Urological & Other Cancer PET-CT
- PET-CT Cost for Urological Cancers in Hyderabad
- PET-CT for Bladder Cancer
- PET-CT for Bone Metastases From Any Cancer
- PET-CT for Brain Tumours: Why MRI Comes First
- PET-CT for Kidney Cancer: Why FDG Is Unreliable
- PET-CT for Melanoma
- PET-CT for Neuroendocrine Tumours: FDG or DOTA?
- PET-CT for Paediatric Cancers
- PET-CT for Rare and Unusual Cancers
- PET-CT for Sarcoma
- PET-CT for Skin and Merkel Cell Cancers
- PET-CT for Testicular Cancer
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
Will PET-CT tell us whether the chemotherapy is working?
It gives a strong indication. A significant drop in FDG uptake between your baseline and response scans suggests cancer cells are dying. The result is not a simple yes or no — there is a spectrum of metabolic response, and your oncologist interprets it alongside examination findings and other tests. The definitive answer comes from the pathology report after surgery, but the scan helps your team plan what to do before that point.
How is the response scan different from the staging scan I had at diagnosis?
Your staging scan mapped where the cancer was and whether it had spread. The response scan asks a different question: has the metabolic activity of the known lesions changed since treatment started? The baseline scan done before chemotherapy is what gives the response scan its reference point — without it, there is nothing meaningful to compare against.
Can I have PET-CT for early-stage breast cancer if I want to?
Your oncologist will advise against it if your stage does not warrant it. This is a clinical decision, not a cost one. In early-stage disease the result would not change what happens next, so the scan would expose you to radiation without providing information that alters your treatment. If you are worried about whether the treatment is working, that concern is worth raising directly with your oncologist rather than seeking a scan the guidelines do not support.
How long does the response scan take, and is it different from the first one?
The process is the same as the baseline scan. You receive the FDG injection and wait roughly an hour for it to distribute before the scan begins. The scanning itself typically takes around 20 to 30 minutes. Preparation — fasting, avoiding strenuous activity beforehand — is the same as before your first scan. Your imaging centre will give you the exact instructions for the day.
Is PET-CT for response assessment available at CION?
Yes. PET-CT is coordinated through partner imaging centres that work with CION, and your oncologist will arrange the scan and receive the report as part of your treatment review. Response-assessment imaging is typically done as part of day care. Ask your team at your next appointment whether a response scan is part of your plan and when it would be scheduled.
What should I ask my oncologist at the next visit?
Ask whether a PET-CT response scan is part of your treatment plan, and if so, when it will be done and what result the oncologist is looking for. Ask what the options are depending on what the scan shows. If a response scan is not planned, ask what is being used to assess response instead. Knowing the plan in advance means you are prepared for whatever the result shows, rather than hearing it unexpectedly on the day of your review.